Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents

Total article views   Abstract views HTML views PDF downloads Totals
1,752 Dovepress* 1,618 100+ 199 1,718
PubMed Central* 0 34 14 34
Totals 1,618 134 213 1,752
*Since 24 October 2018
+Since July 2016

View citations on PubMed Central and Google Scholar